Table of Contents
Gestational Diabetes Mellitus (GDM) is a condition characterized by high blood sugar levels that develop during pregnancy. Early detection through screening is essential to manage risks for both mother and baby. Major health organizations have established guidelines to standardize GDM screening practices worldwide.
Overview of GDM Screening Guidelines
Different health organizations recommend various screening methods and timings, but the goal remains the same: early identification and management of GDM to reduce complications.
Guidelines from Major Health Organizations
American Diabetes Association (ADA)
The ADA recommends screening all pregnant women between 24 and 28 weeks of gestation. The preferred method is the 50-g oral glucose challenge test (GCT), followed by a diagnostic 100-g oral glucose tolerance test (OGTT) if screening is positive. Women with risk factors may be screened earlier.
World Health Organization (WHO)
WHO suggests universal screening for GDM using a 75-g OGTT at 24–28 weeks of gestation. A fasting plasma glucose level ≥5.1 mmol/L (92 mg/dL) or a 2-hour value ≥8.5 mmol/L (153 mg/dL) indicates GDM. They emphasize the importance of timely screening to prevent adverse outcomes.
International Association of Diabetes and Pregnancy Study Groups (IADPSG)
IADPSG recommends a one-step 75-g OGTT for all pregnant women at 24–28 weeks. Diagnosis is made if any of the following plasma glucose values are met or exceeded: fasting ≥5.1 mmol/L (92 mg/dL), 1-hour ≥10.0 mmol/L (180 mg/dL), or 2-hour ≥8.5 mmol/L (153 mg/dL). This approach aims for early detection and intervention.
Comparison of Guidelines
- Timing: Most organizations recommend screening between 24-28 weeks.
- Methods: The ADA favors a two-step approach; WHO and IADPSG recommend a one-step test.
- Thresholds: Vary slightly but aim for early detection and consistent diagnosis criteria.
Understanding these guidelines helps healthcare providers select appropriate screening strategies, ensuring timely diagnosis and management of GDM to improve maternal and neonatal outcomes.